Healthcare -
Biotechnology - NASDAQ - US
$ 20.72
-1.57 %
$ 1.8 B
Market Cap
-4.58
P/E
TVTX - NET INCOME
Net Income TVTX - Travere Therapeutics, Inc.
-376 M
LAST VALUE
-44.56%
2 YEAR CAGR
-29.66%
5 YEAR CAGR
-27.24%
10 YEAR CAGR